The peroxisome proliferator‐activated receptor α regulates amino acid metabolism
暂无分享,去创建一个
W. Wahli | S. Kersten | B. Desvergne | S. Mandard | P. Escher | F. Gonzalez | S. Tafuri | SANDER KERSTEN | STÉPHANE MANDARD | PASCAL ESCHER | FRANK J. GONZALEZ | SHERRIE TAFURI | BÉATRICE DESVERGNE | WALTER WAHLI
[1] T. Saheki,et al. Long‐chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action , 1996, FEBS letters.
[2] J. Corton,et al. Hepatic expression of acute‐phase protein genes during carcinogenesis induced by peroxisome proliferators , 1999, Molecular carcinogenesis.
[3] S. P. Fodor,et al. High density synthetic oligonucleotide arrays , 1999, Nature Genetics.
[4] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[5] R. Young,et al. Biomedical Discovery with DNA Arrays , 2000, Cell.
[6] C. Moncman,et al. Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids. , 1987, Archives of biochemistry and biophysics.
[7] J. Peters,et al. Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription. , 2000, Journal of lipid research.
[8] W. Wahli,et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. , 1999, The Journal of clinical investigation.
[9] D. Kelly,et al. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Bertics,et al. Effect of long-chain fatty acids on triglyceride accumulation, gluconeogenesis, and ureagenesis in bovine hepatocytes. , 1998, Journal of dairy science.
[11] V. Laudet,et al. The Nuclear Receptors Peroxisome Proliferator-activated Receptor α and Rev-erbα Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by Fibrates* , 1998, The Journal of Biological Chemistry.
[12] J. Gustafsson,et al. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. , 1998, Molecular pharmacology.
[13] J. Auwerx,et al. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[14] Sander Kersten,et al. Roles of PPARs in health and disease , 2000, Nature.
[15] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[16] J. Auwerx,et al. Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient Mice* , 1997, The Journal of Biological Chemistry.
[17] D. Lavery,et al. Selective amplification via biotin- and restriction-mediated enrichment (SABRE), a novel selective amplification procedure for detection of differentially expressed mRNAs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Brosnan,et al. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. , 1992, Physiological reviews.
[19] W. Wahli,et al. Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .
[20] T. Pineau,et al. Peroxisome Proliferator-activated Receptor α Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes* , 1998, The Journal of Biological Chemistry.
[21] M. Takiguchi,et al. Hypoglycemia-associated Hyperammonemia Caused by Impaired Expression of Ornithine Cycle Enzyme Genes in C/EBPα Knockout Mice* , 1998, The Journal of Biological Chemistry.
[22] W. Wahli,et al. Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.
[23] J. Bar-Tana,et al. Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs. , 1995, The Journal of Biological Chemistry.
[24] T Hashimoto,et al. Defect in Peroxisome Proliferator-activated Receptor α-inducible Fatty Acid Oxidation Determines the Severity of Hepatic Steatosis in Response to Fasting* , 2000, The Journal of Biological Chemistry.
[25] Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. , 1995, The Journal of clinical investigation.
[26] T. Saheki,et al. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood. , 1997, Journal of biochemistry.
[27] L. Zieve,et al. Effect of fatty acids on the disposition of ammonia. , 1976, The Journal of pharmacology and experimental therapeutics.
[28] T. Kooistra,et al. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha. , 1999, Blood.
[29] J. Bar-Tana,et al. Transcriptional Suppression of the Transferrin Gene by Hypolipidemic Peroxisome Proliferators (*) , 1996, The Journal of Biological Chemistry.
[30] D. Jump,et al. Peroxisome proliferator-activated receptor alpha inhibits hepatic S14 gene transcription. Evidence against the peroxisome proliferator-activated receptor alpha as the mediator of polyunsaturated fatty acid regulation of s14 gene transcription. , 1996, The Journal of biological chemistry.
[31] T. Pineau,et al. Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway. , 1998, Toxicology letters.
[32] P. J. Snodgrass,et al. Coordinate induction of the urea cycle enzymes by glucagon and dexamethasone is accomplished by three different mechanisms. , 1993, Archives of biochemistry and biophysics.